Stock PLUR PLURI INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Pluri Inc.

Equities

PLUR

US72942G2030

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
5.796 USD +0.29% Intraday chart for Pluri Inc. +5.01% +25.03%
Jul. 08 Pluri Inc. Announces ?1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply CI
Jul. 02 Pluri Appoints Liat Zalts as CFO MT

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Alliance Global Lowers Pluristem Therapeutics' Price Target to $4 From $9.50, Maintains Buy Rating
MT
PLURISTEM THERAPEUTICS : Alliance Global Starts Pluristem Therapeutics at Buy with $12.50 Price Target
MT
PLURISTEM THERAPEUTICS : Jefferies Downgrades Pluristem Therapeutics to Hold From Buy; Adjusts PT $6 From $16
MT
PLURISTEM THERAPEUTICS : HC Wainwright Adjusts Pluristem Therapeutics' Price Target to $9 From $15.50, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLUR Stock
  4. News Pluri Inc.
  5. Analyst Reco.